Cancer Care Planning and Communications Act
Summary
HR10087, the Cancer Care Planning and Communications Act, was introduced in the House on August 13, 2026, and referred to the Committees on Energy and Commerce and Ways and Means. The bill would amend Medicare to cover cancer care planning and coordination, but it is in the earliest legislative stage with no cosponsors and no authorized funding. No immediate market impact is expected.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR10087 is an early-stage Medicare authorization bill with no funding specified.
- 2.Zero cosponsors and referral to two committees indicate minimal legislative momentum.
- 3.No immediate market impact; passage in the 119th Congress is unlikely.
Market Implications
There are no direct market implications from this bill at this stage. The healthcare sector is not materially affected by a bill that has not moved beyond referral. Investors should ignore this signal until committee action or cosponsor additions occur.
Full Analysis
On August 13, 2026, Rep. Mark DeSaulnier (D-CA) introduced HR10087, the Cancer Care Planning and Communications Act, in the 119th Congress. The bill was referred to two committees: Energy and Commerce, and Ways and Means. This is a standard procedural step for a bill that proposes changes to Medicare (Title XVIII of the Social Security Act). The bill's text outlines findings on disparities in cancer care and the need for shared decision-making and care coordination, but it does not authorize any specific dollar amount for spending. Instead, it creates a new Medicare benefit category for cancer care planning and coordination services. As an authorization bill, any actual funding would require a separate appropriations process. The bill has zero cosponsors and is in the earliest stage of the legislative process. Given the lack of committee action, no hearings scheduled, and no companion bill in the Senate, the probability of passage in this Congress is very low. The legislative path requires committee markups, House floor vote, Senate passage, and presidential action—all unlikely in the remaining months of the 119th Congress. No specific publicly traded companies are directly impacted at this stage. The bill's provisions, if enacted, could benefit healthcare providers (e.g., oncology practices, hospitals) and health insurers that manage Medicare Advantage plans, but the effect is too speculative and distant to assign tickers with confidence. Retail investors should monitor committee activity and cosponsor additions as signals of momentum, but currently there is no actionable market signal.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →